AskRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6/10
Best for: coverage in all 50 states, which most sellers will not confirm
AskRx falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the plan
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
AskRx sells physician care for brand-name GLP-1s only: Wegovy pen and pill, Zepbound and Foundayo, never compounded. The care fee is $100 a month ($90 physician fee plus $10 fulfillment), and the medication is billed on top at what the site calls pharmacy cost. No medication price is published before intake, and the homepage and the Terms disagree on who dispenses the drug.
Is AskRx legit?
Yes. AskRx is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 6.0/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there an AskRx promo or coupon code?
AskRx has no code to type in. The current offer: New patient intro: $199/mo for first 2 fills (0.25 & 0.5 mg) through 3/31/2026, then $349/mo for all doses. It applies at checkout on its own. Coupon sites advertising an "AskRx promo code" are not a source we can vouch for.
See how AskRx compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to AskRx
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
AskRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Wegovy pen & pill, Zepbound
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How AskRx scores
Six columns, each one computed from something AskRx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.0/10The listed figure is not a comparable monthly price for a named GLP-1 (it may be a membership fee, an insured copay, a per-vial rate or a starting-dose price), so Value is capped rather than scored against other sellers.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
5.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on AskRx
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked FDA warning letters for AskRx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with AskRx involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1AskRx shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask AskRx which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Before you commit, get the ongoing monthly price of the medication itself, not a first-month rate, a membership fee or a per-vial price.
- AskRx serves all 50 states.
Cancelling AskRx
Taken from the terms AskRx publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Generally non-refundable; a refund may be requested within 7 days of the first purchase if no physician consultation has taken place
Medications AskRx lists
AskRx lists Wegovy, Zepbound and Foundayo. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
$90 physician visit fee plus $10 fulfillment fee, charged every month. Medication cost is extra and shown only at checkout.
Same $100 monthly care fee for every medication. Medication cost is extra and shown only at checkout.
Check the price yourself before you pay
Every figure here comes from AskRx's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Serves all 50 states
- We found no FDA warning letters issued to AskRx
Against it
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
What AskRx charges
AskRx lists its fee. The medication is not part of it: the pharmacy or your insurer bills for the drug separately, at its own price, so your monthly total depends on which medication is prescribed and how it is paid for. Before you pay, compare AskRx's cancellation terms with other sellers' cancellation and refund policies. AskRx is not alone in this: about a fifth of GLP-1 sellers publish no price at all.
What AskRx dispenses
AskRx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. These are FDA-approved brand-name products rather than compounded preparations, which is the more expensive route and the one where what is in the pen has been reviewed. Brand names vs molecules sorts out which pen holds which drug. Foundayo is the GLP-1 pill with no fasting rule, approved in April 2026.
Safety and disclosure
AskRx tells you that it treats patients in all 50 states. We found no FDA warning letters issued to AskRx. The FDA publishes seven warning signs for telehealth medicine sellers, and they take a minute to run against AskRx. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want one all-in monthly price. AskRx lists its fee, but the medication is billed separately at its own price.
- You need insurance to cover the cost. Check whether AskRx bills your plan before you start.
It fits if
- you need access wherever you live
Our read
AskRx lists its fee, but the medication is billed separately by the pharmacy or your insurer at its own price. The full monthly cost is the fee plus the drug, so price the drug before you commit. WellMedRx is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
AskRx falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay AskRx
Check today's price, then start the intake.
If you are weighing other sellers, our guide to alternatives to AskRx sets more sellers in the same category beside AskRx on price, states and what the price includes.
Frequently Asked Questions
How to check AskRx yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Connecticut, Florida, Indiana, Iowa, Kansas, Kentucky, New Hampshire, Washington and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this AskRx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See AskRx's current pricing
Whether you qualify is a clinician's decision, made after your intake.